Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03500536 · ClinicalTrials.gov registry record · NA

Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.

A NA study of Depression and Anxiety, sponsored by Actualize Therapy.

Completed
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT03500536 is a NA study of Depression and Anxiety that has completed, run by Actualize Therapy. The registered enrollment target is 146 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03500536, a NA study of Depression and Anxiety, has completed, sponsored by Actualize Therapy.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, cost-effectiveness, and usability of mobile apps.

Interventions

  • BEHAVIORAL IntelliCare

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2018-07-18
Est. Completion 2019-04-04
Phase NA

Sponsor

Actualize Therapy

1 total trials

What the Registry Record Tells You About NCT03500536

The ClinicalTrials.gov registry entry for NCT03500536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The listed sponsor is Actualize Therapy, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IntelliCare is the first listed.

NCT03500536 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT03500536 about?

NCT03500536 is a clinical study titled "Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.". The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, ...

What is the current status of trial NCT03500536?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2018-07-18. Estimated completion is 2019-04-04.

What conditions does trial NCT03500536 study?

This clinical trial studies the following conditions: Depression, Anxiety, Primary Health Care.

What interventions are being tested in trial NCT03500536?

The interventions under investigation include: IntelliCare (BEHAVIORAL).

Who is sponsoring clinical trial NCT03500536?

This trial is sponsored by Actualize Therapy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03500536 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.